Zewei Wang

1.3k total citations
62 papers, 836 citations indexed

About

Zewei Wang is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Zewei Wang has authored 62 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 26 papers in Surgery and 20 papers in Molecular Biology. Recurrent topics in Zewei Wang's work include Bladder and Urothelial Cancer Treatments (22 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Renal cell carcinoma treatment (9 papers). Zewei Wang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (22 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Renal cell carcinoma treatment (9 papers). Zewei Wang collaborates with scholars based in China, Egypt and United States. Zewei Wang's co-authors include Jiejie Xu, Jianming Guo, Li Liu, Yu Xia, Qi Bai, Yu Zhu, Han Zeng, Ying Xiong, Le Xu and Zhaopei Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Agricultural and Food Chemistry.

In The Last Decade

Zewei Wang

58 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zewei Wang China 17 314 310 279 252 163 62 836
Koji Teramoto Japan 18 502 1.6× 338 1.1× 273 1.0× 324 1.3× 130 0.8× 81 1.1k
Shuangshuang Mao China 20 399 1.3× 595 1.9× 300 1.1× 164 0.7× 113 0.7× 38 1.1k
Luc Morat France 18 510 1.6× 367 1.2× 290 1.0× 159 0.6× 88 0.5× 24 1.1k
Seongyeol Park South Korea 17 430 1.4× 322 1.0× 209 0.7× 239 0.9× 129 0.8× 33 971
Feifei Ren China 13 202 0.6× 306 1.0× 115 0.4× 205 0.8× 81 0.5× 27 698
Jiuyang Liu China 10 228 0.7× 248 0.8× 115 0.4× 223 0.9× 87 0.5× 17 677
Chunchao Zhu China 18 323 1.0× 577 1.9× 219 0.8× 318 1.3× 135 0.8× 52 1.2k
Li Xiong China 12 194 0.6× 457 1.5× 684 2.5× 171 0.7× 100 0.6× 32 1.1k

Countries citing papers authored by Zewei Wang

Since Specialization
Citations

This map shows the geographic impact of Zewei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zewei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zewei Wang more than expected).

Fields of papers citing papers by Zewei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zewei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zewei Wang. The network helps show where Zewei Wang may publish in the future.

Co-authorship network of co-authors of Zewei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zewei Wang. A scholar is included among the top collaborators of Zewei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zewei Wang. Zewei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Alhaskawi, Ahmad, Sohaib Hasan Abdullah Ezzi, Yanzhao Dong, et al.. (2024). Recent advancements in the diagnosis and treatment of acral melanoma. Journal of Zhejiang University SCIENCE B. 25(2). 106–122. 1 indexed citations
3.
Wang, Zewei, et al.. (2024). Regulating Schwann Cell Growth by Nanosecond Pulsed Electric Field for Peripheral Nerve Regeneration In Vitro. Journal of Visualized Experiments. 2 indexed citations
4.
Li, Bingyu, Kaifeng Jin, Zhaopei Liu, et al.. (2024). Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer. Cancer Immunology Immunotherapy. 73(4). 66–66. 2 indexed citations
6.
Wang, Zewei, Tonghai Wu, Jishen Zhang, et al.. (2024). Plasma‐Activated Hydrogel Synergies With Paclitaxel to Enhance the Anticancer Efficacy. Plasma Processes and Polymers. 22(2). 2 indexed citations
7.
8.
Liu, Zhongfan, Yanzhao Dong, Zewei Wang, et al.. (2023). [18F]AlF-NOTA-ADH-1: A new PET molecular radiotracer for imaging of N-cadherin-positive tumors. Frontiers in Oncology. 13. 1126721–1126721. 2 indexed citations
9.
Wang, Zewei, Haiying Zhou, Ahmad Alhaskawi, et al.. (2023). Could E-cadherin overexpression promote epithelial differentiation of human adipose-derived stem cells by mediating mesenchymal-to-epithelial transition?. Medical Hypotheses. 171. 111016–111016. 1 indexed citations
11.
Shao, Fei, Kaifeng Jin, Bingyu Li, et al.. (2023). Integrating angiogenesis signature and tumor mutation burden for improved patient stratification in immune checkpoint blockade therapy for muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 41(10). 433.e9–433.e18. 2 indexed citations
12.
Dong, Yanzhao, Haiying Zhou, Ahmad Alhaskawi, et al.. (2023). The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies. Cancers. 15(4). 1193–1193. 22 indexed citations
13.
Zhou, Haiying, Yanzhao Dong, Ahmad Alhaskawi, et al.. (2023). Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management. Cancers. 15(4). 1077–1077. 30 indexed citations
14.
Liu, Zhaopei, Kaifeng Jin, Ziyue Xu, et al.. (2023). Gender disparities in clinical outcomes of urothelial carcinoma linked to X chromosome gene KDM6A mutation. SHILAP Revista de lepidopterología. 2(1). e000199–e000199. 3 indexed citations
15.
Zhou, Haiying, Yanzhao Dong, Ahmad Alhaskawi, et al.. (2022). The Roles of TNF Signaling Pathways in Metabolism of Bone Tumors. Frontiers in Pharmacology. 13. 907629–907629. 4 indexed citations
16.
Liu, Zhaopei, Kaifeng Jin, Han Zeng, et al.. (2022). B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer. European Journal of Cancer. 171. 133–142. 11 indexed citations
17.
Dong, Yanzhao, Haiying Zhou, Ahmad Alhaskawi, et al.. (2022). Alterations in bone fracture healing associated with TNFRSF signaling pathways. Frontiers in Pharmacology. 13. 905535–905535. 5 indexed citations
18.
Wang, Tao, Quan Zhou, Han Zeng, et al.. (2020). CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer. Cancer Immunology Immunotherapy. 69(9). 1855–1867. 40 indexed citations
19.
Qi, Yangyang, Yuan Chang, Zewei Wang, et al.. (2019). Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Cancer Immunology Immunotherapy. 68(12). 2067–2080. 36 indexed citations
20.
Xu, Bin, Yang Wang, Zewei Wang, et al.. (2017). An effective approach to detecting both small and large complexes from protein-protein interaction networks. BMC Bioinformatics. 18(S12). 419–419. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026